176 related articles for article (PubMed ID: 17530505)
21. Increased serum inflammatory markers in the absence of clinical and skeletal muscle inflammation in patients with chronic obstructive pulmonary disease.
Piehl-Aulin K; Jones I; Lindvall B; Magnuson A; Abdel-Halim SM
Respiration; 2009; 78(2):191-6. PubMed ID: 19270439
[TBL] [Abstract][Full Text] [Related]
22. Are systemic inflammatory profiles different in patients with COPD and metabolic syndrome as compared to those with COPD alone?
Stanciu S; Marinescu R; Iordache M; Dumitrescu S; Mureşan M; Bogdan MA
Rom J Intern Med; 2009; 47(4):381-6. PubMed ID: 21179920
[TBL] [Abstract][Full Text] [Related]
23. Circulating matrix metalloproteinase-9 and osteoporosis in patients with chronic obstructive pulmonary disease.
Bolton CE; Stone MD; Edwards PH; Duckers JM; Evans WD; Shale DJ
Chron Respir Dis; 2009; 6(2):81-7. PubMed ID: 19411568
[TBL] [Abstract][Full Text] [Related]
24. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA
Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
[TBL] [Abstract][Full Text] [Related]
25. Circulating visfatin level is correlated with inflammation, but not with insulin resistance.
Oki K; Yamane K; Kamei N; Nojima H; Kohno N
Clin Endocrinol (Oxf); 2007 Nov; 67(5):796-800. PubMed ID: 17634078
[TBL] [Abstract][Full Text] [Related]
26. Structural equation modeling of sleep apnea, inflammation, and metabolic dysfunction in children.
Waters KA; Mast BT; Vella S; de la Eva R; O'Brien LM; Bailey S; Tam CS; Wong M; Baur LA
J Sleep Res; 2007 Dec; 16(4):388-95. PubMed ID: 18036084
[TBL] [Abstract][Full Text] [Related]
27. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.
Thomann R; Rossinelli N; Keller U; Tirri BF; De Geyter C; Ruiz J; Kränzlin M; Puder JJ
Gynecol Endocrinol; 2008 Apr; 24(4):199-206. PubMed ID: 18382906
[TBL] [Abstract][Full Text] [Related]
28. Inflammatory markers, insulin resistance and carotid intima-media thickness in North-Indian type 2 diabetic subjects.
Ahmad J; Ahmned F; Siddiqui MA; Khan AR; Katyal P; Hameed B; Ahmad I
J Assoc Physicians India; 2007 Oct; 55():693-9. PubMed ID: 18173021
[TBL] [Abstract][Full Text] [Related]
29. Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
de Boer JF; Bahr MJ; Böker KH; Manns MP; Tietge UJ
Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G196-201. PubMed ID: 19074645
[TBL] [Abstract][Full Text] [Related]
30. Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy.
Alghasham AA; Barakat YA
Saudi Med J; 2008 Feb; 29(2):185-92. PubMed ID: 18246224
[TBL] [Abstract][Full Text] [Related]
31. Longitudinal follow-up of systemic inflammation after acute exacerbations of COPD.
Groenewegen KH; Dentener MA; Wouters EF
Respir Med; 2007 Nov; 101(11):2409-15. PubMed ID: 17644367
[TBL] [Abstract][Full Text] [Related]
32. Systemic inflammation and mortality in chronic obstructive pulmonary disease.
Sin DD; Man SF
Can J Physiol Pharmacol; 2007 Jan; 85(1):141-7. PubMed ID: 17487253
[TBL] [Abstract][Full Text] [Related]
33. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
[TBL] [Abstract][Full Text] [Related]
34. Markers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patients.
Crul T; Spruit MA; Gayan-Ramirez G; Quarck R; Gosselink R; Troosters T; Pitta F; Decramer M
Eur J Clin Invest; 2007 Nov; 37(11):897-904. PubMed ID: 17883420
[TBL] [Abstract][Full Text] [Related]
35. Systemic inflammatory response to exhaustive exercise in patients with chronic obstructive pulmonary disease.
van Helvoort HA; van de Pol MH; Heijdra YF; Dekhuijzen PN
Respir Med; 2005 Dec; 99(12):1555-67. PubMed ID: 15890510
[TBL] [Abstract][Full Text] [Related]
36. Fat cell size, insulin sensitivity, and inflammation in obese children.
Maffeis C; Silvagni D; Bonadonna R; Grezzani A; Banzato C; Tatò L
J Pediatr; 2007 Dec; 151(6):647-52. PubMed ID: 18035146
[TBL] [Abstract][Full Text] [Related]
37. Levels of inflammatory mediators in chronic obstructive pulmonary disease patients with anemia of chronic disease: a case-control study.
Boutou AK; Pitsiou GG; Stanopoulos I; Kontakiotis T; Kyriazis G; Argyropoulou P
QJM; 2012 Jul; 105(7):657-63. PubMed ID: 22355163
[TBL] [Abstract][Full Text] [Related]
38. Systemic inflammation and metabolic syndrome in stable COPD patients.
Akpınar EE; Akpınar S; Ertek S; Sayın E; Gülhan M
Tuberk Toraks; 2012; 60(3):230-7. PubMed ID: 23030748
[TBL] [Abstract][Full Text] [Related]
39. Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease.
Poulain M; Doucet M; Drapeau V; Fournier G; Tremblay A; Poirier P; Maltais F
Chron Respir Dis; 2008; 5(1):35-41. PubMed ID: 18303100
[TBL] [Abstract][Full Text] [Related]
40. Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study.
Kunisaki KM; Rice KL; Janoff EN; Rector TS; Niewoehner DE
Ther Adv Respir Dis; 2008 Apr; 2(2):55-64. PubMed ID: 19124359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]